Webinar Central

  • About
  • Blog
  • Host Webinar For Free
  • FAQ
  • Free Webinar Calendar
  • Submit Your Webinar
Home

The Investigational Medicinal Product Dossier (IMPD): EU CTA vs. FDA IND: Comparing the Content and Agency Expectation - Webinar By GlobalCompliancePanel

Submitted by Anonymous on Wed, 12/07/2011 - 23:01
01/17/2012 10:00 am
America/Chicago

This 90 minute training course will provide your company the opportunity for comprehensive understanding of the IMPD (Investigational Medicinal Product Dossier) and the structure and content differences between a EU CTA Application and an FDA IND Application. Additionally, this webinar covers many related processes sponsors will need to know, as they file for, conduct and close-out effective clinical studies in the U.S. and EU.

Why you should attend: All sponsors, CROs, Sites and auditors of Clinical Research who are involved in pharmaceutical or biological development need to possess the knowledge and be efficient in completing successful applications for their studies. Knowing what is expected of you and "getting-it-right" the first time, will allow faster development of innovative products. This translates to company and personal success and for new therapies to continue to be available to patient populations worldwide.

Areas Covered In the Session:
US FDA and EU Agency Orientation / Structure
Start –Up and Conducting Clinical Trial Processes
Following Product Registration / Licensing Options
Company Strategy- Linking Clinical Trials & Marketing Authorization Applications
Balancing Strategy and Long Term Regulatory Cost & Maintenance
IMP Dossier & Comparisons of the US IND to the EU CTA Content
Scientific Advice: Member States vs. Pre-IND Meetings with U.S. FDA
Orphan Drugs: EU vs. US Treatment
GCP Compliance Inspections
Essentially Similar and Generic Products
Cross-Agency Interactions: Comparing U.S. FDA and EMA
Effective Interactions with the Global Regulatory Healthcare Authorities
Helpful Websites
Who will benefit: This Webinar will provide invaluable assistance to all personnel in the Pharmaceutical, Biotechnology and CRO industry conducting Clinical Trials including:
Sponsor Senior management
Project Managers
Clinical Trial Heads
Medical writers
Project Managers
CRAs and CRCs
QA / Compliance personnel
Investigators
Clinical Research Scientists
QA / QC Auditors and Staff
Consultants

Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00

webinars@globalcompliancepanel.com
http://www.globalcompliancepanel.com

Phone: 800-447-9407
Fax: 302-288-6884

Webinar Presenters: 
GlobalCompliancePanel
Webinar URL: 
GlobalCompliancePanel
Your rating: None
  • Calendar
Tags:
  • Cross-Agency Interactions
  • EU CTA
  • FDA IND
  • IMP Dossier
  • IMPD
  • Investigational Medicinal Product Dossier
  • online training
  • Orphan Drugs
  • webinars


TwitterCounter for @webinarcentral


GoToWebinar - Web Events Made Easy

Events

« May 2012 »
SunMonTueWedThuFriSat
12345
6789101112
13141516171819
20212223242526
2728293031

Upcoming events

  • Online Seminar Software(Now)
  • Business Mastery Series(Now)
  • Play Therapy Webinar Series(Now)
  • Supporting the Americans with Disabilities Act in Employment - Webinar By TrainHR(1 day)
  • Supplier Controls to Meet Tougher U.S. FDA Requirements - Webinar By ComplianceOnline(1 day)
  • Water System Biofilm Control and Microbial Monitoring Myths - Webinar By GlobalCompliancePanel(1 day)
  • The Essentials of 1031 Exchanges(1 day)
  • FDA Warning Letter - Consent Decree Software Validation(2 days)
  • DHF, DMR, DHR, Technical File and Design Dossier - Key Requirements and Future Directions - Webinar By GlobalCompliancePanel(2 days)
  • Validation of Existing/ Legacy Computer Systems for FDA/EU Compliance - Webinar By ComplianceOnline(2 days)
Add to iCalendar
more

Poll

What's the Best Day to Hold a Webinar?
Monday
0%
Tuesday
38%
Wednesday
13%
Thursday
13%
Friday
38%
Total votes: 8
  • Older polls
I love Smashing Magazine!
Fervens Drupal theme by Leow Kah Thong. Designed by Design Disease and brought to you by Smashing Magazine.